The ABATE trial is studying the effects of a study vaccine named ACI-24.060 in people with early Alzheimer’s disease. A build-up of protein Abeta (Aβ) in the brain is believed to play an important role in cognitive decline in Alzheimer’s disease. ACI-24.060 is designed to help reduce the quantity of ... Read More
All clinical trials
Below is a list of research studies at the NIHR Clinical Research Facility (CRF): Oxford Health.
Some of our studies are recruiting for participants.
To find out more about each individual study please email our team: [email protected]


ABATE Part 2
Part II of the ABATE Study explores the effect of a new vaccine called ACI-24.060 on people with Down’s syndrome. People with Down’s syndrome have an increased risk of developing Alzheimer’s Disease. Alzheimer’s disease is caused by an increased level of ABeta (Aβ) protein leading to slowing down ... Read More
D-CYPHR
We are currently recruiting for the DNA, Children + Young People’s Health Resource (D-CYPHR), a study open to families with children aged 0 to 15 years. Most diseases start in childhood, but most health research is carried out in adults. D-CYPHR wants to change this by getting young people involved ... Read More
GLAD
The Genetic Links to Anxiety and Depression (GLAD) Study is a project set up to support studies exploring risk factors for depression and/or anxiety. We are looking for people with lived experience of anxiety or depression and those who have never experienced any mental health disorder. By studying ... Read More
Study of MK-2214 in Participants with Early Alzheimer’s Disease
This trial is testing an investigational medication in people who have early Alzheimer’s disease. Researchers want to learn about the safety of the investigational medication and how well it may work to slow the progression of Alzheimer’s disease. ... Read More
